HEADER TRANSPORT PROTEIN/IMMUNE SYSTEM 29-MAY-24 8ZOY TITLE CRYO-EM STRUCTURE OF HUMAN NOREPINEPHRINE TRANSPORTER NET BOUND WITH TITLE 2 NOREPINEPHRINE IN AN INWARD OPEN STATE AT A RESOLUTION OF 2.5 TITLE 3 ANGSTROM COMPND MOL_ID: 1; COMPND 2 MOLECULE: SODIUM-DEPENDENT NORADRENALINE TRANSPORTER; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HUMAN NOREPINEPHRINE TRANSPORTER NET,NOREPINEPHRINE COMPND 5 TRANSPORTER,NET,SOLUTE CARRIER FAMILY 6 MEMBER 2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NB_BF9; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: NANOBODY SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC6A2, NAT1, NET1, SLC6A5; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 12 ORGANISM_TAXID: 9844; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NOREPINEPHRINE TRANSPORT, NOREPINEPHRINE, TRANSPORT PROTEIN/IMMUNE KEYWDS 2 SYSTEM, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR A.L.SONG,X.D.WU REVDAT 3 16-OCT-24 8ZOY 1 REMARK REVDAT 2 18-SEP-24 8ZOY 1 JRNL REVDAT 1 11-SEP-24 8ZOY 0 JRNL AUTH A.SONG,X.WU JRNL TITL MECHANISTIC INSIGHTS OF SUBSTRATE TRANSPORT AND INHIBITOR JRNL TITL 2 BINDING REVEALED BY HIGH-RESOLUTION STRUCTURES OF HUMAN JRNL TITL 3 NOREPINEPHRINE TRANSPORTER. JRNL REF CELL RES. 2024 JRNL REFN ISSN 1001-0602 JRNL PMID 39223283 JRNL DOI 10.1038/S41422-024-01024-0 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.500 REMARK 3 NUMBER OF PARTICLES : 612638 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8ZOY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 03-JUN-24. REMARK 100 THE DEPOSITION ID IS D_1300048247. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN NOREPINEPHRINE REMARK 245 TRANSPORTER NET IN COMPLEX WITH REMARK 245 NB_BF9 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : FEI FALCON IV (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2200.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : OTHER REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 47 REMARK 465 PRO A 48 REMARK 465 ARG A 49 REMARK 465 ASP A 50 REMARK 465 GLY A 51 REMARK 465 ASP A 52 REMARK 465 ALA A 53 REMARK 465 GLN A 54 REMARK 465 PRO A 55 REMARK 465 ARG A 56 REMARK 465 GLU A 57 REMARK 465 THR A 58 REMARK 465 TRP A 59 REMARK 465 LEU A 191 REMARK 465 ASN A 192 REMARK 465 GLY A 193 REMARK 465 SER A 194 REMARK 465 VAL A 195 REMARK 465 LEU A 196 REMARK 465 GLY A 197 REMARK 465 ASN A 198 REMARK 465 SER A 259 REMARK 465 GLY A 260 REMARK 465 LYS A 261 REMARK 465 SER B 120 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 829 O HOH A 861 1.96 REMARK 500 O HOH A 838 O HOH A 845 1.96 REMARK 500 O HOH A 823 O HOH A 856 1.96 REMARK 500 O HOH A 802 O HOH A 844 2.03 REMARK 500 OH TYR A 84 OD2 ASP A 473 2.08 REMARK 500 O HOH A 852 O HOH B 208 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 206 -5.57 70.68 REMARK 500 PHE A 523 -50.79 -121.15 REMARK 500 ASP A 546 -118.87 60.15 REMARK 500 ASP B 108 44.03 -143.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PTY A 703 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-60322 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF HUMAN NOREPINEPHRINE TRANSPORTER NET BOUND REMARK 900 WITH NOREPINEPHRINE IN AN INWARD OPEN STATE AT A RESOLUTION OF 2.5 REMARK 900 ANGSTROM REMARK 900 RELATED ID: 8ZP2 RELATED DB: PDB REMARK 900 SAME PROTEIN IN DIFFERENT CONFORMATION. REMARK 900 RELATED ID: EMD-60325 RELATED DB: EMDB REMARK 900 SAME PROTEIN IN DIFFERENT CONFORMATION. REMARK 900 RELATED ID: 8ZP1 RELATED DB: PDB REMARK 900 SAME PROTEIN IN DIFFERENT CONFORMATION. REMARK 900 RELATED ID: EMD-60324 RELATED DB: EMDB REMARK 900 SAME PROTEIN IN DIFFERENT CONFORMATION. DBREF 8ZOY A 47 617 UNP P23975 SC6A2_HUMAN 47 617 DBREF 8ZOY B 1 120 PDB 8ZOY 8ZOY 1 120 SEQRES 1 A 571 ALA PRO ARG ASP GLY ASP ALA GLN PRO ARG GLU THR TRP SEQRES 2 A 571 GLY LYS LYS ILE ASP PHE LEU LEU SER VAL VAL GLY PHE SEQRES 3 A 571 ALA VAL ASP LEU ALA ASN VAL TRP ARG PHE PRO TYR LEU SEQRES 4 A 571 CYS TYR LYS ASN GLY GLY GLY ALA PHE LEU ILE PRO TYR SEQRES 5 A 571 THR LEU PHE LEU ILE ILE ALA GLY MET PRO LEU PHE TYR SEQRES 6 A 571 MET GLU LEU ALA LEU GLY GLN TYR ASN ARG GLU GLY ALA SEQRES 7 A 571 ALA THR VAL TRP LYS ILE CYS PRO PHE PHE LYS GLY VAL SEQRES 8 A 571 GLY TYR ALA VAL ILE LEU ILE ALA LEU TYR VAL GLY PHE SEQRES 9 A 571 TYR TYR ASN VAL ILE ILE ALA TRP SER LEU TYR TYR LEU SEQRES 10 A 571 PHE SER SER PHE THR LEU ASN LEU PRO TRP THR ASP CYS SEQRES 11 A 571 GLY HIS THR TRP ASN SER PRO ASN CYS THR ASP PRO LYS SEQRES 12 A 571 LEU LEU ASN GLY SER VAL LEU GLY ASN HIS THR LYS TYR SEQRES 13 A 571 SER LYS TYR LYS PHE THR PRO ALA ALA GLU PHE TYR GLU SEQRES 14 A 571 ARG GLY VAL LEU HIS LEU HIS GLU SER SER GLY ILE HIS SEQRES 15 A 571 ASP ILE GLY LEU PRO GLN TRP GLN LEU LEU LEU CYS LEU SEQRES 16 A 571 MET VAL VAL VAL ILE VAL LEU TYR PHE SER LEU TRP LYS SEQRES 17 A 571 GLY VAL LYS THR SER GLY LYS VAL VAL TRP ILE THR ALA SEQRES 18 A 571 THR LEU PRO TYR PHE VAL LEU PHE VAL LEU LEU VAL HIS SEQRES 19 A 571 GLY VAL THR LEU PRO GLY ALA SER ASN GLY ILE ASN ALA SEQRES 20 A 571 TYR LEU HIS ILE ASP PHE TYR ARG LEU LYS GLU ALA THR SEQRES 21 A 571 VAL TRP ILE ASP ALA ALA THR GLN ILE PHE PHE SER LEU SEQRES 22 A 571 GLY ALA GLY PHE GLY VAL LEU ILE ALA PHE ALA SER TYR SEQRES 23 A 571 ASN LYS PHE ASP ASN ASN CYS TYR ARG ASP ALA LEU LEU SEQRES 24 A 571 THR SER SER ILE ASN CYS ILE THR SER PHE VAL SER GLY SEQRES 25 A 571 PHE ALA ILE PHE SER ILE LEU GLY TYR MET ALA HIS GLU SEQRES 26 A 571 HIS LYS VAL ASN ILE GLU ASP VAL ALA THR GLU GLY ALA SEQRES 27 A 571 GLY LEU VAL PHE ILE LEU TYR PRO GLU ALA ILE SER THR SEQRES 28 A 571 LEU SER GLY SER THR PHE TRP ALA VAL VAL PHE PHE VAL SEQRES 29 A 571 MET LEU LEU ALA LEU GLY LEU ASP SER SER MET GLY GLY SEQRES 30 A 571 MET GLU ALA VAL ILE THR GLY LEU ALA ASP ASP PHE GLN SEQRES 31 A 571 VAL LEU LYS ARG HIS ARG LYS LEU PHE THR PHE GLY VAL SEQRES 32 A 571 THR PHE SER THR PHE LEU LEU ALA LEU PHE CYS ILE THR SEQRES 33 A 571 LYS GLY GLY ILE TYR VAL LEU THR LEU LEU ASP THR PHE SEQRES 34 A 571 ALA ALA GLY THR SER ILE LEU PHE ALA VAL LEU MET GLU SEQRES 35 A 571 ALA ILE GLY VAL SER TRP PHE TYR GLY VAL ASP ARG PHE SEQRES 36 A 571 SER ASN ASP ILE GLN GLN MET MET GLY PHE ARG PRO GLY SEQRES 37 A 571 LEU TYR TRP ARG LEU CYS TRP LYS PHE VAL SER PRO ALA SEQRES 38 A 571 PHE LEU LEU PHE VAL VAL VAL VAL SER ILE ILE ASN PHE SEQRES 39 A 571 LYS PRO LEU THR TYR ASP ASP TYR ILE PHE PRO PRO TRP SEQRES 40 A 571 ALA ASN TRP VAL GLY TRP GLY ILE ALA LEU SER SER MET SEQRES 41 A 571 VAL LEU VAL PRO ILE TYR VAL ILE TYR LYS PHE LEU SER SEQRES 42 A 571 THR GLN GLY SER LEU TRP GLU ARG LEU ALA TYR GLY ILE SEQRES 43 A 571 THR PRO GLU ASN GLU HIS HIS LEU VAL ALA GLN ARG ASP SEQRES 44 A 571 ILE ARG GLN PHE GLN LEU GLN HIS TRP LEU ALA ILE SEQRES 1 B 120 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 B 120 ALA GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 B 120 PHE PRO VAL THR ASN PHE GLU MET TYR TRP TYR ARG GLN SEQRES 4 B 120 ALA PRO GLY LYS GLU ARG GLU TRP VAL ALA ALA ILE TYR SEQRES 5 B 120 SER THR GLY ILE THR GLU TYR ALA ASP SER VAL LYS GLY SEQRES 6 B 120 ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR VAL SEQRES 7 B 120 TYR LEU GLN MET ASN SER LEU LYS PRO GLU ASP THR ALA SEQRES 8 B 120 VAL TYR TYR CYS ASN VAL LYS ASP ASN GLY ALA TRP ARG SEQRES 9 B 120 GLN ASN TYR ASP TYR TRP GLY GLN GLY THR GLN VAL THR SEQRES 10 B 120 VAL SER SER HET LNR A 701 23 HET CL A 702 1 HET PTY A 703 61 HETNAM LNR L-NOREPINEPHRINE HETNAM CL CHLORIDE ION HETNAM PTY PHOSPHATIDYLETHANOLAMINE HETSYN LNR NORADRENALINE FORMUL 3 LNR C8 H11 N O3 FORMUL 4 CL CL 1- FORMUL 5 PTY C40 H80 N O8 P FORMUL 6 HOH *70(H2 O) HELIX 1 AA1 GLY A 60 VAL A 74 1 15 HELIX 2 AA2 ASP A 75 ASN A 89 1 15 HELIX 3 AA3 GLY A 91 ARG A 121 1 31 HELIX 4 AA4 ALA A 125 ILE A 130 5 6 HELIX 5 AA5 CYS A 131 PHE A 133 5 3 HELIX 6 AA6 PHE A 134 SER A 166 1 33 HELIX 7 AA7 THR A 208 VAL A 218 1 11 HELIX 8 AA8 HIS A 220 SER A 224 5 5 HELIX 9 AA9 GLN A 234 TRP A 253 1 20 HELIX 10 AB1 VAL A 263 ALA A 267 1 5 HELIX 11 AB2 THR A 268 VAL A 282 1 15 HELIX 12 AB3 GLY A 286 LEU A 295 1 10 HELIX 13 AB4 ASP A 298 LYS A 303 5 6 HELIX 14 AB5 GLU A 304 GLY A 320 1 17 HELIX 15 AB6 GLY A 324 SER A 331 1 8 HELIX 16 AB7 ASN A 338 HIS A 372 1 35 HELIX 17 AB8 ASN A 375 ALA A 380 1 6 HELIX 18 AB9 GLY A 383 GLY A 385 5 3 HELIX 19 AC1 LEU A 386 LEU A 398 1 13 HELIX 20 AC2 GLY A 400 PHE A 435 1 36 HELIX 21 AC3 GLN A 436 HIS A 441 1 6 HELIX 22 AC4 HIS A 441 LEU A 458 1 18 HELIX 23 AC5 GLY A 464 ALA A 476 1 13 HELIX 24 AC6 GLY A 478 TRP A 494 1 17 HELIX 25 AC7 GLY A 497 GLY A 510 1 14 HELIX 26 AC8 GLY A 514 PHE A 523 1 10 HELIX 27 AC9 PHE A 523 ASN A 539 1 17 HELIX 28 AD1 PRO A 551 VAL A 567 1 17 HELIX 29 AD2 VAL A 567 THR A 580 1 14 HELIX 30 AD3 SER A 583 THR A 593 1 11 HELIX 31 AD4 PRO A 594 GLU A 597 5 4 HELIX 32 AD5 HIS A 598 ARG A 604 1 7 HELIX 33 AD6 ILE A 606 PHE A 609 5 4 HELIX 34 AD7 GLN A 610 ALA A 616 1 7 HELIX 35 AD8 LYS B 86 THR B 90 5 5 SHEET 1 AA1 2 THR A 544 TYR A 545 0 SHEET 2 AA1 2 TYR A 548 ILE A 549 -1 O TYR A 548 N TYR A 545 SHEET 1 AA2 4 GLN B 3 SER B 7 0 SHEET 2 AA2 4 LEU B 18 SER B 25 -1 O SER B 21 N SER B 7 SHEET 3 AA2 4 THR B 77 MET B 82 -1 O MET B 82 N LEU B 18 SHEET 4 AA2 4 PHE B 67 ASP B 72 -1 N SER B 70 O TYR B 79 SHEET 1 AA3 6 GLY B 10 GLN B 13 0 SHEET 2 AA3 6 THR B 114 SER B 119 1 O SER B 119 N VAL B 12 SHEET 3 AA3 6 ALA B 91 LYS B 98 -1 N ALA B 91 O VAL B 116 SHEET 4 AA3 6 GLU B 33 GLN B 39 -1 N TYR B 35 O ASN B 96 SHEET 5 AA3 6 ARG B 45 ILE B 51 -1 O VAL B 48 N TRP B 36 SHEET 6 AA3 6 THR B 57 TYR B 59 -1 O GLU B 58 N ALA B 50 SHEET 1 AA4 4 GLY B 10 GLN B 13 0 SHEET 2 AA4 4 THR B 114 SER B 119 1 O SER B 119 N VAL B 12 SHEET 3 AA4 4 ALA B 91 LYS B 98 -1 N ALA B 91 O VAL B 116 SHEET 4 AA4 4 ASP B 108 TRP B 110 -1 O TYR B 109 N VAL B 97 SSBOND 1 CYS A 176 CYS A 185 1555 1555 2.04 SSBOND 2 CYS B 22 CYS B 95 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000